The UK’s pharmaceutical sector yesterday warned that its pivotal role in economic growth was under threat, after the government rejected its calls for financial support and tax incentives to promote research and development.

In its official response to an industry-supported report on the life sciences , the Department for Business Enterprise and Regulatory Reform yesterday ruled out calls for new tax credits and deferred demands for additional funding.